Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089445175> ?p ?o ?g. }
- W3089445175 endingPage "780" @default.
- W3089445175 startingPage "780" @default.
- W3089445175 abstract "The aim of the present study was to investigate the association of the pre-treatment C-reactive protein (CRP) plasma level with survival outcomes in a cohort of 423 consecutive patients with locally advanced rectal cancer treated with neo-adjuvant radiochemotherapy followed by surgical resection. To evaluate the prognostic value of the CRP level for clinical endpoints recurrence-free survival (RFS), local-regional control (LC), metastases-free survival (MFS), and overall survival (OS), uni- and multivariate Cox regression analyses were applied, and survival rates were calculated using Kaplan–Meier analysis. The median follow-up time was 73 months. In univariate analyses, the pre-treatment CRP level was a significant predictor of RFS (hazard ratio (HR) 1.015, 95% CI 1.006–1.023; p < 0.001), LC (HR 1.015, 95% CI 1.004–1.027; p = 0.009), MFS (HR 1.014, 95% CI 1.004–1.023; p = 0.004), and OS (HR 1.016, 95% CI 1.007–1.024; p < 0.001). Additionally, univariate analysis identified the MRI circumferential resection margin (mrCRM) and pre-treatment carcinoembryonic antigen (CEA) as significant predictor of RFS (HR 2.082, 95% CI 1.106–3.919; p = 0.023 and HR 1.005, 95% CI 1.002–1.008; p < 0.001). Univariate analysis also revealed a significant association of the mrCRM (HR 2.089, 95% CI 1.052–4.147; p = 0.035) and CEA (HR 1.006, 95% CI 1.003–1.008; p < 0.001) with MFS. Age and CEA were prognostic factors for OS (HR 1.039, 95% CI 1.013–1.066; p = 0.003 and HR 1.005, 95% CI 1.002–1.008; p < 0.001). In multivariate analysis that included parameters with a p-level < 0.20 in univariate analysis, the pre-treatment CRP remained a significant prognostic factor for RFS (HR 1.013, 95%CI 1.001–1.025; p = 0.036), LC (HR 1.014, 95% CI 1.001–1.027; p = 0.031), and MFS (HR 1.013, 95% CI 1.000–1.027; p = 0.046). The results support the hypothesis that an elevated pre-treatment CRP level is a predictor of poor outcome. If confirmed by additional studies, this easily measurable biomarker could contribute to the identification of patients who might be candidates for more aggressive local or systemic treatment approaches or the administration of anti-inflammatory drugs." @default.
- W3089445175 created "2020-10-08" @default.
- W3089445175 creator A5016344736 @default.
- W3089445175 creator A5022444372 @default.
- W3089445175 creator A5036166286 @default.
- W3089445175 creator A5068621564 @default.
- W3089445175 creator A5074918862 @default.
- W3089445175 creator A5089537116 @default.
- W3089445175 date "2020-10-02" @default.
- W3089445175 modified "2023-09-27" @default.
- W3089445175 title "The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant Radiochemotherapy" @default.
- W3089445175 cites W1508586558 @default.
- W3089445175 cites W1554678066 @default.
- W3089445175 cites W17446229 @default.
- W3089445175 cites W1965037168 @default.
- W3089445175 cites W1967417677 @default.
- W3089445175 cites W1986986419 @default.
- W3089445175 cites W1989660739 @default.
- W3089445175 cites W2000439516 @default.
- W3089445175 cites W2000778405 @default.
- W3089445175 cites W2002971944 @default.
- W3089445175 cites W2004473068 @default.
- W3089445175 cites W2005112720 @default.
- W3089445175 cites W2010323349 @default.
- W3089445175 cites W2014982284 @default.
- W3089445175 cites W2017161888 @default.
- W3089445175 cites W2028945958 @default.
- W3089445175 cites W2044018119 @default.
- W3089445175 cites W2044450846 @default.
- W3089445175 cites W2048521619 @default.
- W3089445175 cites W2060425936 @default.
- W3089445175 cites W2062961142 @default.
- W3089445175 cites W2063270450 @default.
- W3089445175 cites W2074346278 @default.
- W3089445175 cites W2095408902 @default.
- W3089445175 cites W2096846592 @default.
- W3089445175 cites W2097903769 @default.
- W3089445175 cites W2115418403 @default.
- W3089445175 cites W2117692326 @default.
- W3089445175 cites W2118278569 @default.
- W3089445175 cites W2123105952 @default.
- W3089445175 cites W2123510004 @default.
- W3089445175 cites W2125452425 @default.
- W3089445175 cites W2128640763 @default.
- W3089445175 cites W2129174325 @default.
- W3089445175 cites W2134613935 @default.
- W3089445175 cites W2137405846 @default.
- W3089445175 cites W2139586102 @default.
- W3089445175 cites W2155492044 @default.
- W3089445175 cites W2158278805 @default.
- W3089445175 cites W2159454395 @default.
- W3089445175 cites W2159619549 @default.
- W3089445175 cites W2164664027 @default.
- W3089445175 cites W2168711381 @default.
- W3089445175 cites W2172458185 @default.
- W3089445175 cites W2275733417 @default.
- W3089445175 cites W2470639362 @default.
- W3089445175 cites W2731409624 @default.
- W3089445175 cites W2798105113 @default.
- W3089445175 cites W2802486935 @default.
- W3089445175 cites W2883286298 @default.
- W3089445175 cites W2894575840 @default.
- W3089445175 cites W2895875588 @default.
- W3089445175 cites W2924871258 @default.
- W3089445175 cites W2966389029 @default.
- W3089445175 cites W2991029116 @default.
- W3089445175 cites W3006410398 @default.
- W3089445175 cites W3010108303 @default.
- W3089445175 cites W3014481596 @default.
- W3089445175 cites W3016743790 @default.
- W3089445175 cites W3017110725 @default.
- W3089445175 cites W3022973322 @default.
- W3089445175 cites W38241211 @default.
- W3089445175 cites W4244315786 @default.
- W3089445175 cites W79833968 @default.
- W3089445175 doi "https://doi.org/10.3390/diagnostics10100780" @default.
- W3089445175 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7601888" @default.
- W3089445175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33023215" @default.
- W3089445175 hasPublicationYear "2020" @default.
- W3089445175 type Work @default.
- W3089445175 sameAs 3089445175 @default.
- W3089445175 citedByCount "5" @default.
- W3089445175 countsByYear W30894451752021 @default.
- W3089445175 countsByYear W30894451752022 @default.
- W3089445175 countsByYear W30894451752023 @default.
- W3089445175 crossrefType "journal-article" @default.
- W3089445175 hasAuthorship W3089445175A5016344736 @default.
- W3089445175 hasAuthorship W3089445175A5022444372 @default.
- W3089445175 hasAuthorship W3089445175A5036166286 @default.
- W3089445175 hasAuthorship W3089445175A5068621564 @default.
- W3089445175 hasAuthorship W3089445175A5074918862 @default.
- W3089445175 hasAuthorship W3089445175A5089537116 @default.
- W3089445175 hasBestOaLocation W30894451751 @default.
- W3089445175 hasConcept C10515644 @default.
- W3089445175 hasConcept C121608353 @default.
- W3089445175 hasConcept C126322002 @default.
- W3089445175 hasConcept C143998085 @default.
- W3089445175 hasConcept C144301174 @default.